Fluorine in PDB 6gzd: Crystal Structure of Human CSNK1A1 with A86

All present enzymatic activity of Crystal Structure of Human CSNK1A1 with A86:
2.7.11.1;

The structure of Crystal Structure of Human CSNK1A1 with A86, PDB code: 6gzd was solved by Y.Ben-Neriah, A.Venkatachalam, W.Minzel, A.Fink, I.Snir-Alkalay, J.Vacca, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	29.31 / 2.28
Space group	I 41
Cell size a, b, c (Å), α, β, γ (°)	113.383, 113.383, 80.878, 90.00, 90.00, 90.00
R / Rfree (%)	17.5 / 22.1

The binding sites of Fluorine atom in the Crystal Structure of Human CSNK1A1 with A86 (pdb code 6gzd). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of Human CSNK1A1 with A86, PDB code: 6gzd:

Fluorine binding site 1 out of 1 in the Crystal Structure of Human CSNK1A1 with A86


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of Human CSNK1A1 with A86 within 5.0Å range: probe atom residue distance (Å) B Occ A:F1018 b:61.6 occ:1.00 F A:LCI1018 0.0 61.6 1.0 C6 A:LCI1018 1.3 46.3 1.0 C5 A:LCI1018 2.4 42.6 1.0 C7 A:LCI1018 2.4 46.3 1.0 C15 A:LCI1018 2.7 49.3 1.0 C8 A:LCI1018 2.8 48.7 1.0 SD A:MET90 3.2 81.7 1.0 CG A:MET90 3.6 68.9 1.0 N5 A:LCI1018 3.6 46.4 1.0 N2 A:LCI1018 3.6 41.2 1.0 CE A:MET90 3.7 83.0 1.0 N4 A:LCI1018 4.0 53.4 1.0 C4 A:LCI1018 4.1 44.8 1.0 C9 A:LCI1018 4.2 54.3 1.0 O A:ASP91 4.4 48.5 1.0 CB A:ALA44 4.6 53.0 1.0 CD1 A:LEU93 4.6 49.1 1.0 N3 A:LCI1018 4.7 57.5 1.0 CB A:MET90 4.9 62.8 1.0 CG2 A:ILE156 5.0 53.0 1.0

W.Minzel, A.Venkatachalam, A.Fink, E.Hung, G.Brachya, I.Burstain, M.Shaham, A.Rivlin, I.Omer, A.Zinger, S.Elias, E.Winter, P.E.Erdman, R.W.Sullivan, L.Fung, F.Mercurio, D.Li, J.Vacca, N.Kaushansky, L.Shlush, M.Oren, R.Levine, E.Pikarsky, I.Snir-Alkalay, Y.Ben-Neriah. Small Molecules Co-Targeting Cki Alpha and the Transcriptional Kinases CDK7/9 Control Aml in Preclinical Models. Cell V. 175 171 2018.
ISSN: ISSN 1097-4172
PubMed: 30146162
DOI: 10.1016/J.CELL.2018.07.045